Skip to content
Governance Register

← US public companies

Rapport Therapeutics, Inc.

SEC CIK 2012593 · RAPP · last insider filing 2026-06-10

Directors (from insider filings)

NameCapacity as filedFilings
Maraganore John Director filed 2024 - 2026
Paul Steven M Director filed 2024 - 2026
Healy James Director filed 2024 - 2026
Perez Robert J Director filed 2024 - 2026
Silva Paul M Director filed 2024 - 2026
Huber Reid M Director filed 2024 - 2026
Sanchez Ramiro Director filed 2024 - 2026
Young Wendy B. Director filed 2024 - 2026
Ceesay Abraham Director · Chief Executive Officer filed 2024 - 2026
Tong Jeffrey K Director filed 2024 - 2024
Burrell Terry-Ann Director filed 2024 - 2024

Officers (from insider filings)

NameTitle as filedFilings
Yeleswaram Krishnaswamy Chief Development Officer filed 2024 - 2026
Gault Cheryl Chief Operations Officer filed 2024 - 2026
Bredt David Chief Scientific Officer filed 2024 - 2026
Ignelzi Troy A. Chief Financial Officer filed 2024 - 2026
Sevigny Jeffrey Chief Medical Officer filed 2025 - 2026
Galer Bradley S. Chief Medical Officer filed 2024 - 2024

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.